Synaptic Pharmaceutical Corp Sample Contracts

AutoNDA by SimpleDocs
MAY, 1996
Synaptic Pharmaceutical Corp • February 10th, 1997 • Services-commercial physical & biological research
Non-Plan Option NONTRANSFERABLE NONQUALIFIED STOCK OPTION AGREEMENT
Nonqualified Stock Option Agreement • November 14th, 2002 • Synaptic Pharmaceutical Corp • Biological products, (no disgnostic substances) • New Jersey
ST&B DRAFT 10/23/97 2,500,000 Shares of Common Stock SYNAPTIC PHARMACEUTICAL CORPORATION UNDERWRITING AGREEMENT ____________, 1997
Synaptic Pharmaceutical Corp • October 30th, 1997 • Services-commercial physical & biological research • New York
AMENDMENT NO. 1 TO COOPERATION AGREEMENT ---------------------
Cooperation Agreement • November 6th, 1998 • Synaptic Pharmaceutical Corp • Services-commercial physical & biological research
EXHIBIT 10.36 AMENDMENT NO. 2 AND SUPPLEMENT TO RESEARCH COLLABORATION AND LICENSE AGREEMENT
Collaboration and License Agreement • March 21st, 1997 • Synaptic Pharmaceutical Corp • Services-commercial physical & biological research
COLLABORATIVE RESEARCH AND LICENSE AGREEMENT
Collaborative Research and License Agreement • November 7th, 1997 • Synaptic Pharmaceutical Corp • Services-commercial physical & biological research • New Jersey
RESEARCH AND LICENSE AGREEMENT
Research and License Agreement • February 10th, 1997 • Synaptic Pharmaceutical Corp • Services-commercial physical & biological research • New York
EXHIBIT 10.40 ------------- AMENDMENT NO. 4 TO RESEARCH COLLABORATION AND LICENSE AGREEMENT
Research Collaboration and License Agreement • March 27th, 1998 • Synaptic Pharmaceutical Corp • Services-commercial physical & biological research
AND
Option and License Agreement • March 25th, 1999 • Synaptic Pharmaceutical Corp • Services-commercial physical & biological research
ISO Plan Option NONTRANSFERABLE INCENTIVE STOCK OPTION AGREEMENT
Nontransferable Incentive Stock Option Agreement • November 14th, 2002 • Synaptic Pharmaceutical Corp • Biological products, (no disgnostic substances) • New Jersey
NQL Plan Option NONTRANSFERABLE NONQUALIFIED STOCK OPTION AGREEMENT
Nontransferable Nonqualified Stock Option Agreement • November 14th, 2002 • Synaptic Pharmaceutical Corp • Biological products, (no disgnostic substances) • New Jersey
AGREEMENT AND PLAN OF MERGER Dated as of November 21, 2002, Among H. LUNDBECK A/S, VIKING SUB CORPORATION And SYNAPTIC PHARMACEUTICAL CORPORATION
Agreement and Plan of Merger • November 22nd, 2002 • Synaptic Pharmaceutical Corp • Biological products, (no disgnostic substances) • Delaware
EXHIBIT 10.36 ------------- AMENDMENT NO. 3 AND SUPPLEMENT TO RESEARCH COLLABORATION AND LICENSE AGREEMENT
Synaptic Pharmaceutical Corp • March 27th, 1998 • Services-commercial physical & biological research
SECOND AMENDMENT TO RIGHTS AGREEMENT
Rights Agreement • November 22nd, 2002 • Synaptic Pharmaceutical Corp • Biological products, (no disgnostic substances) • Delaware

SECOND AMENDMENT, dated as of November 21, 2002 (the "Amendment"), to the Rights Agreement, dated as of December 11, 1995 and amended on October 19, 2001 (as amended, the "Rights Agreement"), between Synaptic Pharmaceutical Corporation, a Delaware corporation (the "Company"), and Mellon Investor Services LLC (formerly known as Chemical Mellon Shareholder Services), as rights agent (the "Rights Agent").

AGREEMENT BETWEEN
Synaptic Pharmaceutical Corp • March 27th, 1998 • Services-commercial physical & biological research
AutoNDA by SimpleDocs
SUBLEASE
Synaptic Pharmaceutical Corp • May 11th, 2000 • Services-commercial physical & biological research • New Jersey
Time is Money Join Law Insider Premium to draft better contracts faster.